Lunaphore is developing the next-generation tissue diagnostics platform for the analysis and classification of tumors and other solid tissues. Based on a proprietary microfluidic chip technology, a bench top device and software the platform offers customers unprecedented speed, accuracy and flexibility. Lunaphore’s unique solution meets today’s needs, where medicine is becoming more personalized and whole panels of biomarkers play an increasing role.